Anti-lipids Flashcards

1
Q

macromolecular complexes in the blood that transport lipids

A

lipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

proteins on surface of lipoprtoeins

A

apolipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

enzyme that catalyzes rate-liming step in cholesterol

A

HMG-CoA reducttase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

enzyme found on surface of endothelial cells that release free fatty acids from triglycerides

A

lipoprotein lipase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what transport cholesterol and TGs from GI tract to body

A

chylomicrons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TG-rich lipoproteins, precursor to LDL

A

VLDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What can cause high cholesterol genetically?

A
  • familial hypercholesterolemia
  • familial hypertriglyceridemia
  • familial combined hyperlipidemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are contributing conditions for HLD

A

DM, alcoholism, obesity, CKD, glucocorticoids, OCPs, cyclosporine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

FLP

A

fasting lipid profile
- total cholesterol
- LDL
- HDL
- TGs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When do you start monitoring lipids?

A

20+ every 4-6 years, annually for higher risk patients
frequency based on family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Friedwald equation to

A

calculate LDL

LDL = TC - (HDL+(tris/5))
not accurate when tris>400

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Target lipid levels

A

LDL: <100
HDL >60
TGS <150

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Target lifestyle

A

reduce saturated fats, increase omega-3s
at least 150min/week of exercise
weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

most common and effective drug class to decrease LDL, reduce inflammation, stabilize plaques

A

statins (HMG-CoA reductase inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What medications inhibit cholesterol synthesis + bind circulating LDL, stabilize plaques, inhibit thrombus, anti-inflammatory?

A

statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are ADRs of statins?

A

headache, arthralgia, MYALGIA, fatigue, flu-llike symptoms, myopathy and rhabdomyolysis
hepatotoxicity (monitor LFTs - if high, then severe hepatotoxicity)
signs of damage/labs persist = jaundice, light stools, dark urine, hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What combo with statins are not good?

A

macrolides, cyclosporine, azole antifungals, HIV protease inhibitors, verapamil, gemfibrozil, niacin, amiodarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What should you monitor with statins?

A

Cr and CK - check baseline + with symptoms

D/C drug if CK>19 x ULN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How do you treat statin myopathy?

A

CoQ-10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are DDIs with statins?

A

grapefruit with atorvastatin, simvastatin, lovastatin (3A4)
rosuvastatin 2C9
pravastatin = no CYP450

21
Q

What are CIs of statins?

A
  • pregnancy (no in any child-bearing age)
  • liver disease
  • severe illness, trauma, surgery
22
Q

What med:
- lowers LDL + TGs, increases HDL
- decreased hepatic production of VLDL -> less LDL + trigs

A

niacin (vitamin B3): nicotinic acid

23
Q

What are ADRs of niacin

A

lots-
flushing (can take aspirin beforehand and avoid alcohol, spicy foods, hot showers/baths after taking)
hyperglycemia
hyperuricemia
GI upset
hepatotoxicity

24
Q

What are CIs of niacin?

A

active or chronic liver disease, severe gout, caution in DM + PUD

25
Q

How do you monitor niacin?

A
  • LFTs baseline, q2-3 months for the first year, then periodically
    LFTs >/3xUNL = discontinue
  • glucose + uric acid levels baseline, 6-8 weeks, yearly, adverse effects
26
Q

What is a cholesterol absorption inhibitor that lowers absorption in intestine>

A

ezetimibe (zetia)

27
Q

Should you add ezetimibe to statins?

28
Q

Consider ____ if maximum statin dose with <50% LDL goal or LDL >100

29
Q

What are ADRs of zetia?

A

monotherapy = URI, diarrhea, arthralgias, sinusitis
w/ statin = nasopharyngitis, myalgias, everything else

30
Q

What are CIs of zetia?

A

avoid: cyclosporine, fibrates (increase)
separate administration: bile acid sequestrants (decrease)

31
Q

What do you monitor with zetia?

A

LFTs, CK, adverse events

32
Q

What med reduces LDL but can cause GI side effects?

A

bile acid sequestrants
- cholesytramine (questran)
- colesevelem (welchol)
- colestipol (colestid)

33
Q

Binds bile acids in intestine + impedes reabsorption
decrease LDL by 15-30%
** triglycerides may increase **

A

bile acid sequestrants

34
Q

When
<50% reduction in LDL on max statin or LDL > 70
zetia intolerant and triglycerides <300

A

add bile acid sequestrants

35
Q

What are ADRs of bile acid sequestrants?

A

GI upset, N/V, bloating, constipation, abdominal pain

36
Q

bile acid sequestrants have _____ DDIs

A

manyyyy - decreases absorption of other drugs - should be taken 4 hours before or after other drugs

37
Q

activates lipoprotein lipase which leads to reduction in triglycerides, inducing synthesis of HDL

38
Q

What to use with hypertriglyceridemia >500

A

fibrates

gemfibrozil (lopid), fenofibrate (tricor)

39
Q

What are ADRs of fibrates?

A

GI upset, gallstones, constipation, myalgia, increase in LFTs

40
Q

What are CIs of fibrates?

A
  • renal impairment (CrCL <30)
  • hepatic impariment
  • use caution w/ Hx of gallbladder disease
  • monitor: LFTs at baseline, 3 months after, annually
41
Q

What are DDIs of fibrates?

A

increased risk of rhabdomyolysis especially gemfibrozil (less with fenofibrate)
warfarin = increases bleeding risk
sulfonylureas = increase effect, MONITOR BS

42
Q

What are PCSK9 inhibitors

A

praluent (alirocumab) and repatha (evolocumab) - SQ q2-4 weeks

43
Q

Meds that inhibit PCSK9 from degrading LDL receptors

A

PCSK9 inhibitors

44
Q

What can you add with patient <50% LDL reduction on max statin and LDL >70 and familial hypercholesteremia?

A

PCSK9 inhibitors
up to 60% reduction

45
Q

What are ADRs of PCSK9 inhibitors?

A

nasopharyngitis, injection site reactions, back pain
- expensive, SQ injection, burdensome

46
Q

Who should be treated?

A

1) ASCVD
2) LDL >/190
3) 40-75 w/ DM
4) LDL 70-189 w/ 10 year risk >7.5%
5) assess other risk factors

47
Q

Lifestyle changes for

A

primary first line intervention

48
Q

Statins are first line for

A

secondary prevention of CAD